| Literature DB >> 31635261 |
Alessandro Attanzio1, Antonella D'Anneo2, Francesco Pappalardo3, Francesco Paolo Bonina4, Maria Antonia Livrea5, Mario Allegra6, Luisa Tesoriere7.
Abstract
Manna, a very singular vegetable product derived from the spontaneous solidification of the sap of some Fraxinus species, has long been known for its mild laxative and emollient properties. In this work, a hydro-alcoholic extract of manna (HME) from Sicilian Fraxinus angustifolia Vahl was investigated using HPLC-DAD to find phenol components and using chemical and biological in vitro assays to determine its reducing, antioxidant and anti-inflammatory capacity. We identified elenolic acid, tyrosol, hydroxytyrosol, catechin, fraxetin, verbascoside, gallic acid, procyanidin-B1, and luteolin 3,7 glucoside, in order of abundance. Measurements of total antioxidant activity by Folin-Ciocalteu reaction and ferric reducing ability (FRAP), as well as of scavenger activity towards ABTS•+, DPPH•, and perferryl-myoglobin radicals, showed that the phytocomplex effectively reduced oxidants with different standard potentials. When compared with vitamin E, HME also behaved as an efficient chain-breaking antioxidant against lipoperoxyl radicals from methyl linoleate. In cellular models for oxidative stress, HME counteracted membrane lipid oxidation of human erythrocytes stimulated by tert-butyl hydroperoxide and prevented the generation of reactive oxygen species, as well as the GSH decay in IL-1β-activated intestinal normal-like cells. Moreover, in this in vitro intestinal bowel disease model, HME reduced the release of the pro-inflammatory cytokines IL-6 and IL-8. These findings may suggest that manna acts as an antioxidant and anti-inflammatory natural product in humans, beyond its well-known effects against constipation.Entities:
Keywords: Fraxinus; antioxidant; intestinal bowel disease model; manna; manna bioactivity; phytochemicals; red blood cell oxidation; reducing power
Year: 2019 PMID: 31635261 PMCID: PMC6826888 DOI: 10.3390/antiox8100494
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1HPLC-DAD chromatogram of hydro-alcoholic extract of manna (HME) with identification of phenolic compounds. Revelation was at 280 nm, 330 nm and 346nm.
Phytochemicals identified in manna extract from Fraxinus angustifolia Vahl.
| Class | Compound | mg/Kg |
|---|---|---|
|
| Gallic acid | 4.12 ± 0.32 |
|
| Tyrosol | 36.66 ± 0.25 |
|
| Hydroxytyrosol | 13.33 ± 0.40 |
|
| Fraxetin | 4.74 ± 1.02 |
|
| Verbascoside | 4.5 ± 0.21 |
|
| Catechin | 5.86 ± 0.52 |
| Luteolin 3,7 glucoside | 1.45 ± 0.35 | |
| Procyanidin B1 | 3.69 ± 0.34 | |
| Quercitin 3-O-glucoside | n.d. | |
| Oleuropein | n.d. | |
| Elenolic acid | 250 ± 4.78 |
Manna was extracted and treated as described in Methods. The values are the mean ± SD of two different extractions and three HPLC runs for each sample (n = 6). n.d., not detected.
Reducing capacity and Radical scavenger activity of manna extract.
| TAA a | FRAP | ABTS•+ | DPPH• | •Mb[FeIV=O] Deactivation Rate |
|---|---|---|---|---|
|
|
|
|
|
|
a TAA; Total Antioxidant Activity. b GAE; Gallic Acid Equivalent. c AAE; Acid Ascorbic Equivalent. d TE; Trolox Equivalent. Values are the mean ± SD of four determinations carried in triplicate.
Figure 22,2′-azobis(2,4-dimethyl-valeronitrile) (AMVN)-induced oxidation of methyl linoleate in methanol in the absence (control) or in the presence of HME. Oxidation conditions and HPLC analysis of methyl linoleate hydoperoxides are reported in methods. Vit E was used as a positive control. Each point represents the mean ± SD of three determinations carried out in triplicate with different incubation mixtures.
Figure 3HME inhibits membrane lipid oxidation of human erythrocytes stimulated by tert-butyl hydroperoxide. Cell oxidation conditions and HPLC analysis of malondialdehyde (MDA) are reported in the methods section. Vit E was used as a positive control. Each point represents the mean ± SD of three determinations carried out in triplicate with different incubation mixtures.
Figure 4HME inhibits the generation of reactive oxygen species (A) and the GSH decay (B) in IL-1β-activated intestinal normal-like cells. Arithmetic means ± SD (n = 9) of2’,7’-dichlorofluorescin diacetate (DCFDA)-associated mean fluorescence intensity (MFI) (A) and 5-chloromethylfluorescein diacetate (CMFDA)-associated MFI after 24 h incubation of differentiated CaCo 2 cells with IL-1β preceded by 1 h pre-treatment in the presence of HME or vehicle. Bars with different letters are significantly different with p < 0.05 (Anova associated with Tukey test).
Figure 5HME inhibits the release of the pro-inflammatory cytokines IL-8 (A) and IL-6 (B) in IL-1β-activated intestinal normal-like cells. Arithmetic means ± SD (n = 9) of the values after 24 h incubation of differentiated CaCo 2 cells with IL-1β preceded by 1 h pre-treatment in the presence of HME or vehicle. Release of cytokines in the cell incubation medium was measured by ELISA. Bars with different letters are significantly different with p < 0.05 (Anova associated with Tukey test).